UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`AddIESS. COMMISSIONER FOR PATENTS
`PO Box 1450
`Alexandria, Viigmia 22313-1450
`www.uspto.gov
`
`
`
`
`F ING OR 371 (C) DATE
`
`
`
`APPLICATION NUMBER
`
`FIRST NAMED APPLICANT
`
`ATTY. DOCKET NO./TITLE
`
`14/493,903
`
`09/23/2014
`
`Shirou SAWA
`
`2014-1250
`CONFIRMATION NO. 7395
`
`513
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`PUBLICATION NOTICE
`
`IIIIIIIIIIIIIIIIIIIIIIIIILIIIII
`
`
`
`IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIILOOOOO
`
`Title:AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC
`ACID
`
`Publication No.US-2015-0011634-A1
`Publication Date:01/08/2015
`
`NOTICE OF PUBLICATION OF APPLICATION
`
`The above-identified application will be electronically published as a patent application publication pursuant to 37
`CFR 1.211, et seq. The patent application publication number and publication date are set forth above.
`
`The publication may be accessed through the USPTO's publically available Searchable Databases via the
`Internet at www.uspto.gov. The direct link to access the publication is currently http://www.uspto.gov/patft/.
`
`The publication process established by the Office does not provide for mailing a copy of the publication to
`applicant. A copy of the publication may be obtained from the Office upon payment of the appropriate fee set forth
`in 37 CFR 1.19(a)(1). Orders for copies of patent application publications are handled by the USPTO's Office of
`Public Records. The Office of Public Records can be reached by telephone at (703) 308-9726 or (800) 972-6382,
`by facsimile at (703) 305-8759, by mail addressed to the United States Patent and Trademark Office, Office of
`Public Records, Alexandria, VA 22313-1450 or via the Internet.
`
`In addition, information on the status of the application, including the mailing date of Office actions and the
`dates of receipt of correspondence filed in the Office, may also be accessed via the Internet through the Patent
`Electronic Business Center at www.uspto.gov using the public side of the Patent Application Information and
`Retrieval (PAIR) system. The direct link to access this status information is currently http://pair.uspto.gov/. Prior to
`publication, such status information is confidential and may only be obtained by applicant using the private side of
`PAIR.
`
`Further assistance in electronically accessing the publication, or about PAIR, is available by calling the Patent
`Electronic Business Center at 1-866-217-9197.
`
`
`
`Office of Data Managment, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`Page 1 of 366
`
`LUPIN EX 1048
`
`LUPIN EX 1048
`
`Page 1 of 366
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMIVHSSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`14/493,903
`
`ISSUE DATE
`
`01/06/2015
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`8927606
`
`2014—1250
`
`7395
`
`513
`
`7590
`
`12/17/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`Suite 400 East
`
`Washington, DC 20005-1503
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above—identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above—identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pair.uspto. gov for additional applicants):
`
`Shirou SAWA, Hyogo, JAPAN;
`SENJU PHARMACEUTICAL CO., LTD., Osaka, JAPAN, Assignee (with 37 CFR 1.172 Interest);
`Shuhei FUJITA, Hyogo, JAPAN;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (1239119303) Of 366
`
`Page 2 of 366
`
`

`

`(311111111010 211111511111 11115; 1111111, 11113501111111 11-1111 11111111131111:.l'eeis}.t1): 1111,1111,
`
`PA RT 13 ~ FEEt’S) TRANSMI".1"II=‘1.L
`
`3111111811111 1851.1'1? 1Eit
`1unlnlissimwr 1111‘ Patents
`P1} 3111: 14511
`«91112111111111‘111, V“ginia "12511344511
`
`01: £1111; (5713—273-2S85
`
`
`
`
`
`
`11111111211 ..‘
`‘1
`13111111.;
`1131311
`25111111111
`111: 11111111113111! when:
`(11511141111111).
`‘3: 1111.1 1111111 1111111111111:
`1
`..
`'Z~
`1111‘. 1S
`.1? FEE 111111 1‘1131..1(.~‘1"'.111)1\1“ 1131::
`11.11 11.111131111111311;
`
`
`1111 1.11;! master! 11:1 the cum::1! 1‘01‘1'
`”Messy: 1111111‘w‘k
`1
`1111;111:1111.
`.. 11' 1'111‘11‘11‘
`~<
`111111.\1\1‘11111‘111 1111111111113: 1111‘. 1111113111311
`311 1.13 211111 1311111111
`111 11f 111111111‘1111111‘1;
`
`
`:1 11:111111111;
`ADDR'
`1111113111111 11111-313 1:111;'1‘1.11‘11 111:1:111'1'11 {111111-311 01111111111». 111 1111011111}- 111} 1111:011yi11g :1. 1111.11- 11.111111111011111: 11111111113: 111111.111; {b} 11111112111111;
`31131111811111‘11‘81'131‘. 11085113110315.
`
`
`1111‘
`‘1 11:1111‘11‘1111': pf 1112111111,: 1.1111110);
`N '
`1.1:;- 11s~11 11.»; 1111111121111 111;:
`1‘1 111
`
`
`
`1..
`11311111111" H155. 113.1111"!
`113131111112 hr. 11511911 11'.)
`‘
`“pun-1:15;
`
`
`
`111111.11 111111141151. 1111111
`5:111'11 as 1111.
`{1111113.
`1:111:11 111111111
`211111111.
`1.11-1‘ 115 mm lit‘l‘iifil.1111‘ 01' 51115111110 151‘ Ll.11‘1\1111\\5011
`7.91111“c419 1'11 Hailing 131‘ Trammisskm- 111-11 «1111 1111:. 1.:1:111:11
`
`
`
`
`.
`.13 1111111 1'33 311 8111.1: 111311:
`
`..
`{11113113.
`1'11 being £11:51111111:
`.. 1:11 1111‘. 11111‘ 11111111111111 1‘1‘10'11'.
`
`
`(.‘if-RI-{E-N'I' 1' .{1 Ex
`
`II."
`
`
`
`,
`1'31"
`
`
`i1 {130 1.3111 111111111. N.W..
`Suite. 400 1321111
`Washingmn, D117. 21.10115- 1503
`
`
`
`
`
`
`
`' A11131113.:‘1'1'1GN NU. FIRING: 1311133 1",1R8'1'NA3V11'1‘1) .1N’V‘1'LN'E'"'JIR 11’1"}"1'2‘RNEEY IKIK'.‘ K1311 NO.
`14149? .9113
`119137152111 «=1
`311111.111 5515071531
`2111411250
`'5 '?1.“5
`
`
`1111.1; 01" 1NVEN1'11'JN: AQT'
`:3.
`. 1
`ZC‘YL»)PPH£N‘614‘1 "1:111? ACID
`
`
`
`
`
`
` 1.3.41?1'13 151312.
`
`1.1111.11$1‘_‘1‘>11.\“1'1;:1‘51
`1321’ 1 9.1201 5
` 111311;.11‘111'111011111
`
`
`
`_
`_
`.. ..
`1.
`._;._._..
`‘
`
`
`\MFNQFRC‘TH 1WD 13, pamfif‘g 1
`1?..15'111‘11111111111; 1:11 1111‘. 1111119111 fit-111 55191:. 1191'
`1 1211;151519111'1‘01111‘[1115;111:5112 511111113528 111‘ 53111113551111} 111' ”11:1: .-'\1'1{.1R‘T§R" (33’
`1 p
`'1'"R 16""
`..s 111' up 11.1 '1 1155111111.:1‘csd 111111111 111111111111
`1 -------------------------------------------------------------------
`
`
`111‘‘111‘1‘ 2111111131
`
`111 ag-‘nts 1“:11. 11111111111111»
`'3 {7111111151 111' can
`'1
`-
`1
`.
`Addfi‘is; 1mm 1"“ '
`
`
`
`12.1:1111111111111.
`
`1111' ”Ami; 1’11 3. wiggle {11m 33,31:an35-: 11 131111111‘t‘1' 1}
`-—...................................................................
`
`
`'1111'1'11:11111;1Bi11
`111111-11.
`'
`.111 "
`11111111 1111‘. 111111111 01“ up11':
`
`
`
`113412111'1111'111‘ 1
`11:.) 1111115111311.
`111 s 111 51511~111.<..11 1111 mum is
`
`
`
`1...‘
`1
`
`11
`
`1911' is 111111111191! 1.16.1111», 1111': 111xz11111m11 11111 11121311 111911 1'111‘
`
`7
`>
`‘
`.
`am M11 1111118111 13111 1111."111111‘M 11'1111 :1
`51111912
`is 11111111511111! 1.111111». 1111115.
`.111
`'
`
` 11133113111111 .15. 3111 1111111 in .1.
`
`
`(11.111111181111111. 01 1111‘s: 11.31111 15. No.1 11 :1111151111111‘ 1111‘ 11111113 1111 11111111111 111.
`L "R 3.11.
`11.1) R1.1$11)1.i:\‘ 13.11: 11:.T11Y and 51.31113 (11?. (3015511113711
`
`1111 ‘171111.1ng 11110131114111111111111-
`
`1‘11'1' :11!
`
`3
`
`1:.A1NAMZE OF ASSIGNEE
`
`SENJU PHARMACEUT1CAL (313., LTD.
`
`QSAKA, JAPAN
`
`
`1911:3139 that}; 1111‘
`:1;.1;.1111px‘11111‘ 113113111111 15111651111131 111. 11111131111113 111111 11111 111‘. {1111111111111 1111': {11111111} :
`1.1 11111111111111! 1.] €. 11111117311011 1:11 11111111 [Mn-1111‘. 111111.151 13111113' 1.} 1.111111:11111111111
`
`41‘. 1111511111.1111'1-"1:1;1'§1‘. {Please £111.11 Napply 111131“ 1111111111151,1 [mid 11.411111: {1‘14 fihfi'fi'fl 111111159}
`4'1. {1111‘ 11111111111111 11:11:15} 1111: 31113111111311:
`1211111‘1‘1‘1‘JA 111111113 \‘fflfi.‘-f¢.¥7f:t1.
`11.1 Public11111111 1'1‘1‘ (No 31111111 11111111.: 1111131111111 11111111111211)
`=35} 121111111211111111113111111.111:1'111111111111611111‘1111111111‘1111“
`'1“.111211.111:\.~. 1'11 (11211118 am-
`‘
`1JA1111111119 01-11111 ~ 1; 111 1.111111.-1 ______________________________________________
`53111: 1110:1101 11' 111311.111- 111111.11112111 111 chargc 111311.141111'111 fest' ‘
`
`1'.11-'1<rp11}.'1111‘111. In .1M139'351'15 31111111111 511111116123139151‘111‘11'131‘. :m (<11111' cam 11? this 1111111}
`
`:7. (image in {11115131 81my, 11mm #155115 5111111‘1551‘'11 15111.»“1‘ j
`:3 Apph’wns 11111131ng 1:111:11: c1111; 1111135. See..11 1.11)».
`
`
`1‘?
`11113131- 111.11
`13131131 and 1511'}. issue
`
`’
`,
`,
`' 111.111.1111 111.1111 csctifi'caiiur: 131' 111111111 131111131
`
`13112.11 :11 {111‘ 111
`111
`.1 [1.111 1:111 1111 1111:1111111111111‘5111.
`mem in 1111‘. micro 1'1‘1111'5‘ 311111115111 wii! “1'11 11“ 11.1
` fer: p
`U 91115111131111 331111111155; 21111111 11531111» 51111113. SW: 11'? CPR 1.33
`\(____)_______1'1"'.' 11 13m.'11311111111111“ was 115‘“. 111mb 111111131 1111131111 14111ij 31111113. 1151111551] 11115 box “1111.16 1.1.11111
`1111111 111111111111111'1111 111111111 111' 15111111111211 11:1 11111311 1-1111: 5.1111115
`,...
`
`1
`
`1...! 1319111111111“ changi 11g 111 11‘. 3111111 11.11111511111111311 101‘. 11.151171.
`1.
`'1
`- '.
`Di
`“111.11111 11115- 1111.1 11111 11‘ ”18.11.81! 111119 1111111111111111011 151111511':1"‘11111¥1:1111':111 111 511131101 1111:."11:
`si hed :3
`itall
`
`
`..1«‘ 11111114511
`g
`y
`'5
`..
`:
`N11115: 111313111111; 1.111131, 1.11‘ 1113111:
`111 1111:1111
`11111‘1‘ 111111 31"1'1'1JlNfidanartEh. M1£h§él€§rk 11.111111 511111111111 1:1“. 1111-1111131.113 and1.21:.1‘11fin-111141118.
`
`
`
`:3:WC ee @We” e'o'
`'Com'
`November 2‘1 20151
`
`Cheek Jr./
`
`
`__aLe:2.11.14.11.2113:01:08.:95100'
`11111-1
`
`AME-“1'3“? 312111111111: __
`
`
`'1"}‘111‘.11 111‘ 1151111131 11.11511:
`11111111311111 011198511________________________________________________________________
`R12131's11111'1'111‘1 :.\"11_ ______ 33387_______________________________________________________
`
`Page 3 of 366
`
`11:11:11: 2 1.11"}
`
`P10185 151111131: '10 1111\1'113‘1011311111111111: iiumgh 11.1“.711;-0.3."
`
`(31131131155141033
`
`U..\.' 1311112111 11111.1 1111111111111}; 0117103: 13'. 53'. 1315115111111}
`
`5‘51 13151‘1}\~11\ "
`
`Page 3 of 366
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Filing Date:
`
`23-Sep-2014
`
`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`Utility under 35 USC111(a) Filing Fees
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD($)
`
`_—
`
`
`
`Basic Filing:
`
`Miscellaneous Filing:
`
`Patent Appeals and-Interference:
`
`Post-Al|owance-and-Post-lssuance:
`
`Extensarééofi-yrggé
`
`Page 4 of 366
`
`

`

`Miscellaneous:
`
`Total in USD (5)
`
`Page 5 of 366
`
`Page 5 of 366
`
`

`

`T'tle °f Inventwn‘
`
`AQUEOUS LIQUID PREPARATION CONTAINING 2-AMINO-3-(4-
`BROMOBENZOYL)PHENYLACETIC ACID
`
`Electronic Acknowledgement Receipt
`
`“—
`
`——
`
`
`
`——
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`RAM confirmation Number
`
`Deposit Account
`
`Authorized User
`
`yes
`
`Credit Card
`
`555
`
`230975
`
`CHEEKJR., WARREN M.
`
`figg'ggagmgditional Fees required under 37 C.F.R. Section 1.17 (Patent application and reexamination processing fees)
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.16 (National application filing, search, and examination fees)
`
`Page 6 of 366
`
`

`

`Charge any Additional Fees required under 37 C.F.R. Section 1.19 (Document supply fees)
`
`Charge any Additional Fees required under 37 C.F.R. Section 1.20 (Post Issuance fees)
`
`Charge any Additional Fees required under 37 C. F. R. Section 1. 21 (Miscellaneous fees and charges)
`
`File Listing:
`
`Document
`
`.
`
`.
`
`File Size(Bytes)/
`
`Multi
`
`Pages
`
`Issue Fee Payment (PTO-85B)
`
`AttachA_IF.pdf
`
`415516
`
`ddf1617e8025bf921e65a2b7ad88412e8a
`c2d1
`
`The PDF file has been signed with a digital signature and the legal effect of the document will be based on the contents of the file not the
`digital signature.
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`1363e483d9503e897c14300d4941ebc9a13
`9c76f
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`lfa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and ofthe International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Page 7 of 366
`
`Page 7 of 366
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`513
`
`7590
`
`11/19/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`5.1.400];
`
`Washington, DC 20005-1503
`
`
`
`
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 11/19/2014
`
`14/493,903
`
`09/23/2014
`
`Shirou SAWA
`
`2014—1250
`
`7395
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`02/ 1 9/201 5
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED.
`SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`Page 8 of 366
`PTOL—85 (Rev. 02/11)
`
`Page 1 0f 3
`
`Page 8 of 366
`
`

`

`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`PO. Box 1450
`Alexandria, Virginia 22313-1450
`or m (571)-273-2885
`
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`péJropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`n icated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`a i
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change ofaddFESS)
`
`11/19/2014
`7590
`513
`WENDEROTH, LIND & PONACK, L...LP
`1030 15th St
`t N W
`.
`1‘66 ’
`'
`Su1te 400 East
`
`"
`
`Washlngton, DC 20005-1503
`
`Note: A certificate of mailin can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any other accompanying
`fiapers. Each additional paper, such as an assignment or formal drawing, must
`ave its own certificate of mailing or transmission.
`
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273—2885, on the date indicated below.
`
`(Date)
`
`(Depositorsname)
`(Signature)
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
` F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/493,903
`
`09/23/2014
`
`Shirou SAWA
`
`2014— 1250
`
`7395
`
`TITLE OF INVENTION: AQUEOUS LIQUID PREPARATION CONTAINING 2—AMINO—3—(4—BROMOBENZOYL)PHENYLACETIC ACID
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`02/ 1 9/201 5
`
`EXAMINER
`
`ART UNIT
`
`CLASS-SUB CLASS
`
`SOROUSH, LAYLA
`
`1627
`
`514—619000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`
`3 Chan e of correspondence address (or Change of Correspondence
`Address orm PTO/SB/ 122) attached.
`
`
`
`
`
`2
`
`3
`
`3 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03—02 or more recent) attached. Use of a Customer
`Vumber is required.
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`2. For printing on the patent front page, list
`(1) The names of up to 3 registered patent attorneys
`1
`or agents OR, alternatively,
`(2) The name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`'3 Individual
`
`'3 Corporation or other private group entity '3 Government
`
`4a. The following fee(s) are submitted:
`3 Issue Fee
`
`
`
`3 Publication Fee (No small entity discount permitted)
`3 Advance Order — # of Copies
`
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 A check is enclosed.
`
`3 Payment by credit card. Form PTO—2038 is attached.
`3 The director is hereby authorized to charge the required fee(s), any deficiency, or credits any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`
`
`5. Change in Entity Status (from status indicated above)
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`
`3 Applicant asserting small entity status. See 37 CFR 1.27
`
` 3 Applicant changing to regular undiscounted fee status.
`
`NOTE: Absent a valid certification of Micro Entity Status (see forms PTO/SB/ 15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`NOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: This form must be signed in accordance with 37 CFR 1.31 and 1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`Authorized Signature
`
`Typed or printed name
`
`
`Date
`
`Registration No.
`
`Page 9 of 366
`
`Page 2 of 3
`
`PTOL—85 Part B (10—13) Approved for use through 10/31/2013.
`
`OMB 0651—0033
`
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Page 9 of 366
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NO.
`
`FILING DATE
`
`
`
`
`F {ST NAMED INVENTOR
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/493,903
`
`09/23/2014
`
`Shirou SAWA
`
`2014—1250
`
`7395
`
`513
`
`7590
`
`11/19/2014
`
`WENDEROTH, LIND & PONACK, L.L.P.
`1030 15th Street, N.W.,
`5.1640013...
`
`Washington, DC 20005-1503
`
`SOROUSH,LAYLA
`
`1627
`
`DATE MAILED: 11/19/2014
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`(Applications filed on or after May 29, 2000)
`
`The Office has discontinued providing a Patent Term Adjustment (PTA) calculation with the Notice of Allowance.
`
`to eliminate the
`Section 1(h)(2) of the AIA Technical Corrections Act amended 35 U.S.C. 154(b)(3)(B)(i)
`requirement that the Office provide a patent term adjustment determination with the notice of allowance. See
`Revisions to Patent Term Adjustment, 78 Fed. Reg. 19416, 19417 (Apr. 1, 2013). Therefore, the Office is no longer
`providing an initial patent term adjustment determination with the notice of allowance. The Office will continue to
`provide a patent term adjustment determination with the Issue Notification Letter that is mailed to applicant
`approximately three weeks prior to the issue date of the patent, and will include the patent term adjustment on the
`patent. Any request for reconsideration of the patent term adjustment determination (or reinstatement of patent term
`adjustment) should follow the process outlined in 37 CFR 1.705.
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)—272—7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1—(888)—786—0101 or (571)—272—4200.
`
`Page 10 of 366
`PTOL—85 (Rev. 02/11)
`
`Page 3 0f 3
`
`Page 10 of 366
`
`

`

`OMB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires Federal agencies to obtain Office of Management and
`Budget approval before requesting most types of information from the public. When OMB approves an agency
`request to collect information from the public, OMB (i) provides a valid OMB Control Number and expiration
`date for the agency to display on the instrument that will be used to collect the information and (ii) requires the
`agency to inform the public about the OMB Control Number’s legal significance in accordance with 5 CFR
`1320.5(b).
`
`The information collected by PTOL-85 Part B is required by 37 CFR 1.311. The information is required to obtain
`or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`depending upon the individual case. Any comments on the amount of time you require to complete this form
`and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, PO. Box 1450, Alexandria, Virginia 22313-1450. DO NOT
`SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, PO. Box
`1450, Alexandria, Virginia 22313-1450. Under the Paperwork Reduction Act of 1995, no persons are required to
`respond to a collection of information unless it displays a valid OMB control number.
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (PL. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant
`to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is
`35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which
`the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination of
`proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records
`may be disclosed to the Department of Justice to determine whether disclosure of these records is required
`by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance
`from the Member with respect to the subject matter of the record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to
`comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`responsibility to recommend improvements in records management practices and programs, under authority
`of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations
`governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive.
`Such disclosure shall not be used to make determinations about individuals.
`
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication
`of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the
`record was filed in an application which became abandoned or in which the proceedings were terminated
`and which application is referenced by either a published application, an application open to public
`inspection or an issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`Page equrcfé‘gent agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`Page 11 of 366
`
`

`

`
`
`Notice of Allowability
`
`Application No.
`
`14/493,903
`Examiner
`
`Applicant(s)
`
`SAWA ET AL.
`Art Unit
`
`LAYLA SOROUSH
`
`1627
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address--
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application.
`If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. IX This communication is responsive to the TD filed on 11/5/14l 11/06/14 and approved on 11/6/14 and 11/7/14.
`
`2. I] An election was made by the applicant in response to a restriction requirement set forth during the interview on
`requirement and election have been incorporated into this action.
`
`; the restriction
`
`3. IZI The allowed claim(s) is/are 19-48.
`
`4. IX Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119( )-(d) or (f).
`
`a) IX All
`
`b) [I Some*
`
`c) [I None
`
`of the:
`
`1. El Certified copies of the priority documents have been received.
`
`.
`
`2. IX Certified copies of the priority documents have been received in Application No. 10/525,006.
`
`3. El Copies of the certified copies of the priority documents have been received in this national stage application from the
`
`International Bureau (PCT Rule 17.2( )).
`
`* Certified copies not received:
`
`Applicant has THREE MONTHS FROM THE “MAILING DATE” of this communication to file a reply complying with t